Drawing for ENCYCLE

USPTO serial 86952001

ENCYCLE

Reviewed by CopyMark Law Group

Reg. 5830828Status 710
Filing date
Status date
Registration date
Aug 13, 2019
Examiner
EVANKO, PATRICIA MALESARDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ENCYCLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Byer

DAVID J. BYER K&L GATES LLPONE LINCOLN STREETSTATE STREET FINANCIAL CENTERBOSTON, MA 02111

Goods and services

ClassDescriptionStatusFirst use
036Brokerage services, namely, acquisition and divestiture of patent and intellectual property rights arising from medical and pharmaceutical research and development activities; Brokerage services to commercialize research and development outcomes in the field of medicine, pharmacy, biology, chemistry and medicine-technology; Brokerage services to commercialize research and development projects in the field of medicine, pharmacy, biology, chemistry and medicine-technologySECTION 8 - CANCELLED—
042Pharmaceutical drug development services, namely, the synthesis of macrocycles using amphoteric reagents for drug discovery and discovery of new therapeutic uses for existing pharmaceutical preparations; Research in the field for chemistry for the discovery and production of therapeutic pharmaceutical preparations; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical research services; Scientific research and analysis in the field of drug discovery and pharmaceutical drug development; Drug discovery services; Pharmaceutical research services; Pharmaceutical research and development; Clinical research in the field of gastroenterological science and medicine; Development of pharmaceutical preparations and medicines; Pharmaceutical evaluation services; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific information to scientists, physicians and health care providers; Scientific research, pharmaceutical research, medical research, technical consultation and product development for others in the field of development of pharmaceuticalsSECTION 8 - CANCELLED—
045Licensing of patent and intellectual property rights arising from medical and pharmaceutical research and development activities; Licensing of proprietary intellectual propertySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 27, 2026C8..CANCELLED SEC. 8 (6-YR)—
Aug 13, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 13, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 8, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jul 8, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 24, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 24, 2019D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Apr 11, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 9, 2019EX2GSOU EXTENSION 2 GRANTED—
Apr 9, 2019EXT2SOU EXTENSION 2 FILED—
Apr 9, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 8, 2018EX1GSOU EXTENSION 1 GRANTED—
Oct 8, 2018EXT1SOU EXTENSION 1 FILED—
Oct 8, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2018DOCKASSIGNED TO EXAMINER—
Apr 10, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 13, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 8, 2018FIXDELECTRONIC RECORD REVIEW COMPLETE—
Dec 29, 2017ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Dec 21, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 21, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 21, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2017ALIEASSIGNED TO LIE—
Dec 13, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 12, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jul 12, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Jul 12, 2017CNSISUSPENSION INQUIRY WRITTEN—
Jan 11, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 11, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Jan 11, 2017CNSLSUSPENSION LETTER WRITTEN—
Dec 20, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 20, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 20, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 20, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2016DOCKASSIGNED TO EXAMINER—
Mar 30, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Mar 29, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 28, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance